|
||||||
|
 | Fusion Gene Summary |
| Fusion Gene ORF analysis |
| Fusion Genomic Features |
| Fusion Protein Features |
| Fusion Gene Sequence |
| Fusion Gene PPI analysis |
| Related Drugs |
| Related Diseases |
Fusion gene:HNRNPA2B1-ATG5 (FusionGDB2 ID:36905) |
Fusion Gene Summary for HNRNPA2B1-ATG5 |
 Fusion gene summary |
| Fusion gene information | Fusion gene name: HNRNPA2B1-ATG5 | Fusion gene ID: 36905 | Hgene | Tgene | Gene symbol | HNRNPA2B1 | ATG5 | Gene ID | 3181 | 9474 |
| Gene name | heterogeneous nuclear ribonucleoprotein A2/B1 | autophagy related 5 | |
| Synonyms | HNRNPA2|HNRNPB1|HNRPA2|HNRPA2B1|HNRPB1|IBMPFD2|RNPA2|SNRPB1 | APG5|APG5-LIKE|APG5L|ASP|SCAR25|hAPG5 | |
| Cytomap | 7p15.2 | 6q21 | |
| Type of gene | protein-coding | protein-coding | |
| Description | heterogeneous nuclear ribonucleoproteins A2/B1HNRNPA2B1/MYC fusionepididymis secretory sperm binding proteinhnRNP A2 / hnRNP B1nuclear ribonucleoprotein particle A2 protein | autophagy protein 5APG5 autophagy 5-likeATG5 autophagy related 5 homologapoptosis-specific protein | |
| Modification date | 20200314 | 20200313 | |
| UniProtAcc | P22626 | Q9H1Y0 | |
| Ensembl transtripts involved in fusion gene | ENST00000476233, ENST00000354667, ENST00000356674, | ENST00000343245, ENST00000369070, ENST00000369076, ENST00000360666, ENST00000475645, | |
| Fusion gene scores | * DoF score | 43 X 37 X 14=22274 | 15 X 12 X 7=1260 |
| # samples | 50 | 15 | |
| ** MAII score | log2(50/22274*10)=-5.47728875772656 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(15/1260*10)=-3.0703893278914 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | |
| Context | PubMed: HNRNPA2B1 [Title/Abstract] AND ATG5 [Title/Abstract] AND fusion [Title/Abstract] | ||
| Most frequent breakpoint | HNRNPA2B1(26240192)-ATG5(106649964), # samples:1 | ||
| Anticipated loss of major functional domain due to fusion event. | HNRNPA2B1-ATG5 seems lost the major protein functional domain in Hgene partner, which is a CGC due to the frame-shifted ORF. HNRNPA2B1-ATG5 seems lost the major protein functional domain in Hgene partner, which is a essential gene due to the frame-shifted ORF. | ||
| * DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
| Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
| Partner | Gene | GO ID | GO term | PubMed ID |
| Hgene | HNRNPA2B1 | GO:0006397 | mRNA processing | 2557628 |
| Hgene | HNRNPA2B1 | GO:0006406 | mRNA export from nucleus | 10567417 |
| Hgene | HNRNPA2B1 | GO:0031053 | primary miRNA processing | 26321680 |
| Hgene | HNRNPA2B1 | GO:0050658 | RNA transport | 17004321 |
| Hgene | HNRNPA2B1 | GO:1990428 | miRNA transport | 24356509 |
| Fusion gene breakpoints across HNRNPA2B1 (5'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
| Fusion gene breakpoints across ATG5 (3'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
| Fusion gene information from two resources (ChiTars 5.0 and ChimerDB 4.0) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| Source | Disease | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| ChimerDB4 | STAD | TCGA-CD-8525-01A | HNRNPA2B1 | chr7 | 26240192 | - | ATG5 | chr6 | 106649964 | - |
Top |
Fusion Gene ORF analysis for HNRNPA2B1-ATG5 |
| Open reading frame (ORF) analsis of fusion genes based on Ensembl gene isoform structure. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| intron-3CDS | ENST00000476233 | ENST00000343245 | HNRNPA2B1 | chr7 | 26240192 | - | ATG5 | chr6 | 106649964 | - |
| intron-3CDS | ENST00000476233 | ENST00000369070 | HNRNPA2B1 | chr7 | 26240192 | - | ATG5 | chr6 | 106649964 | - |
| intron-3CDS | ENST00000476233 | ENST00000369076 | HNRNPA2B1 | chr7 | 26240192 | - | ATG5 | chr6 | 106649964 | - |
| intron-3CDS | ENST00000476233 | ENST00000360666 | HNRNPA2B1 | chr7 | 26240192 | - | ATG5 | chr6 | 106649964 | - |
| intron-5UTR | ENST00000476233 | ENST00000475645 | HNRNPA2B1 | chr7 | 26240192 | - | ATG5 | chr6 | 106649964 | - |
| In-frame | ENST00000354667 | ENST00000343245 | HNRNPA2B1 | chr7 | 26240192 | - | ATG5 | chr6 | 106649964 | - |
| In-frame | ENST00000354667 | ENST00000369070 | HNRNPA2B1 | chr7 | 26240192 | - | ATG5 | chr6 | 106649964 | - |
| In-frame | ENST00000354667 | ENST00000369076 | HNRNPA2B1 | chr7 | 26240192 | - | ATG5 | chr6 | 106649964 | - |
| Frame-shift | ENST00000354667 | ENST00000360666 | HNRNPA2B1 | chr7 | 26240192 | - | ATG5 | chr6 | 106649964 | - |
| 5CDS-5UTR | ENST00000354667 | ENST00000475645 | HNRNPA2B1 | chr7 | 26240192 | - | ATG5 | chr6 | 106649964 | - |
| In-frame | ENST00000356674 | ENST00000343245 | HNRNPA2B1 | chr7 | 26240192 | - | ATG5 | chr6 | 106649964 | - |
| In-frame | ENST00000356674 | ENST00000369070 | HNRNPA2B1 | chr7 | 26240192 | - | ATG5 | chr6 | 106649964 | - |
| In-frame | ENST00000356674 | ENST00000369076 | HNRNPA2B1 | chr7 | 26240192 | - | ATG5 | chr6 | 106649964 | - |
| Frame-shift | ENST00000356674 | ENST00000360666 | HNRNPA2B1 | chr7 | 26240192 | - | ATG5 | chr6 | 106649964 | - |
| 5CDS-5UTR | ENST00000356674 | ENST00000475645 | HNRNPA2B1 | chr7 | 26240192 | - | ATG5 | chr6 | 106649964 | - |
| ORFfinder result based on the fusion transcript sequence of in-frame fusion genes. |
| Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | Seq length (transcript) | BP loci (transcript) | Predicted start (transcript) | Predicted stop (transcript) | Seq length (amino acids) |
| ENST00000354667 | HNRNPA2B1 | chr7 | 26240192 | - | ENST00000343245 | ATG5 | chr6 | 106649964 | - | 2494 | 175 | 1035 | 1328 | 97 |
| ENST00000354667 | HNRNPA2B1 | chr7 | 26240192 | - | ENST00000369070 | ATG5 | chr6 | 106649964 | - | 2494 | 175 | 1035 | 1328 | 97 |
| ENST00000354667 | HNRNPA2B1 | chr7 | 26240192 | - | ENST00000369076 | ATG5 | chr6 | 106649964 | - | 2494 | 175 | 1035 | 1328 | 97 |
| ENST00000356674 | HNRNPA2B1 | chr7 | 26240192 | - | ENST00000343245 | ATG5 | chr6 | 106649964 | - | 2494 | 175 | 1035 | 1328 | 97 |
| ENST00000356674 | HNRNPA2B1 | chr7 | 26240192 | - | ENST00000369070 | ATG5 | chr6 | 106649964 | - | 2494 | 175 | 1035 | 1328 | 97 |
| ENST00000356674 | HNRNPA2B1 | chr7 | 26240192 | - | ENST00000369076 | ATG5 | chr6 | 106649964 | - | 2494 | 175 | 1035 | 1328 | 97 |
| DeepORF prediction of the coding potential based on the fusion transcript sequence of in-frame fusion genes. DeepORF is a coding potential classifier based on convolutional neural network by comparing the real Ribo-seq data. If the no-coding score < 0.5 and coding score > 0.5, then the in-frame fusion transcript is predicted as being likely translated. |
| Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | No-coding score | Coding score |
| ENST00000354667 | ENST00000343245 | HNRNPA2B1 | chr7 | 26240192 | - | ATG5 | chr6 | 106649964 | - | 0.7074645 | 0.29253545 |
| ENST00000354667 | ENST00000369070 | HNRNPA2B1 | chr7 | 26240192 | - | ATG5 | chr6 | 106649964 | - | 0.7074645 | 0.29253545 |
| ENST00000354667 | ENST00000369076 | HNRNPA2B1 | chr7 | 26240192 | - | ATG5 | chr6 | 106649964 | - | 0.7074645 | 0.29253545 |
| ENST00000356674 | ENST00000343245 | HNRNPA2B1 | chr7 | 26240192 | - | ATG5 | chr6 | 106649964 | - | 0.7074645 | 0.29253545 |
| ENST00000356674 | ENST00000369070 | HNRNPA2B1 | chr7 | 26240192 | - | ATG5 | chr6 | 106649964 | - | 0.7074645 | 0.29253545 |
| ENST00000356674 | ENST00000369076 | HNRNPA2B1 | chr7 | 26240192 | - | ATG5 | chr6 | 106649964 | - | 0.7074645 | 0.29253545 |
Top |
Fusion Genomic Features for HNRNPA2B1-ATG5 |
| FusionAI prediction of the potential fusion gene breakpoint based on the pre-mature RNA sequence context (+/- 5kb of individual partner genes, total 20kb length sequence). FusionAI is a fusion gene breakpoint classifier based on convolutional neural network by comparing the fusion positive and negative sequence context of ~ 20K fusion gene data. From here, we can have the relative potentency of the 20K genomic sequence how individual sequnce will be likely used as the gene fusion breakpoints. |
| Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | 1-p | p (fusion gene breakpoint) |
| Distribution of 44 human genomic features loci across 20kb length fusion breakpoint regions. We integrated a total of 44 different types of human genomic feature loci information across five big categories including virus integration sites, repeats, structural variants, chromatin states, and gene expression regulation. More details are in help page. |
| Distribution of 44 human genomic features loci across 20kb length fusion breakpoint regions that are ovelapped with the top 1% feature importance score regions. More details are in help page. |
Top |
Fusion Protein Features for HNRNPA2B1-ATG5 |
| Go to FGviewer for the breakpoints of chr7:26240192-chr6:106649964 - FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels. |
 |
| Main function of each fusion partner protein. (from UniProt) |
| Hgene | Tgene |
| HNRNPA2B1 | ATG5 |
| FUNCTION: Heterogeneous nuclear ribonucleoprotein (hnRNP) that associates with nascent pre-mRNAs, packaging them into hnRNP particles. The hnRNP particle arrangement on nascent hnRNA is non-random and sequence-dependent and serves to condense and stabilize the transcripts and minimize tangling and knotting. Packaging plays a role in various processes such as transcription, pre-mRNA processing, RNA nuclear export, subcellular location, mRNA translation and stability of mature mRNAs (PubMed:19099192). Forms hnRNP particles with at least 20 other different hnRNP and heterogeneous nuclear RNA in the nucleus. Involved in transport of specific mRNAs to the cytoplasm in oligodendrocytes and neurons: acts by specifically recognizing and binding the A2RE (21 nucleotide hnRNP A2 response element) or the A2RE11 (derivative 11 nucleotide oligonucleotide) sequence motifs present on some mRNAs, and promotes their transport to the cytoplasm (PubMed:10567417). Specifically binds single-stranded telomeric DNA sequences, protecting telomeric DNA repeat against endonuclease digestion (By similarity). Also binds other RNA molecules, such as primary miRNA (pri-miRNAs): acts as a nuclear 'reader' of the N6-methyladenosine (m6A) mark by specifically recognizing and binding a subset of nuclear m6A-containing pri-miRNAs. Binding to m6A-containing pri-miRNAs promotes pri-miRNA processing by enhancing binding of DGCR8 to pri-miRNA transcripts (PubMed:26321680). Involved in miRNA sorting into exosomes following sumoylation, possibly by binding (m6A)-containing pre-miRNAs (PubMed:24356509). Acts as a regulator of efficiency of mRNA splicing, possibly by binding to m6A-containing pre-mRNAs (PubMed:26321680). Plays also a role in the activation of the innate immune response (PubMed:31320558). Mechanistically, senses the presence of viral DNA in the nucleus, homodimerizes and is demethylated by JMJD6 (PubMed:31320558). In turn, translocates to the cytoplasm where it activates the TBK1-IRF3 pathway, leading to interferon alpha/beta production (PubMed:31320558). {ECO:0000250|UniProtKB:A7VJC2, ECO:0000269|PubMed:10567417, ECO:0000269|PubMed:24356509, ECO:0000269|PubMed:26321680, ECO:0000303|PubMed:19099192}.; FUNCTION: (Microbial infection) Involved in the transport of HIV-1 genomic RNA out of the nucleus, to the microtubule organizing center (MTOC), and then from the MTOC to the cytoplasm: acts by specifically recognizing and binding the A2RE (21 nucleotide hnRNP A2 response element) sequence motifs present on HIV-1 genomic RNA, and promotes its transport. {ECO:0000269|PubMed:15294897, ECO:0000269|PubMed:17004321}. | FUNCTION: Involved in autophagic vesicle formation. Conjugation with ATG12, through a ubiquitin-like conjugating system involving ATG7 as an E1-like activating enzyme and ATG10 as an E2-like conjugating enzyme, is essential for its function. The ATG12-ATG5 conjugate acts as an E3-like enzyme which is required for lipidation of ATG8 family proteins and their association to the vesicle membranes. Involved in mitochondrial quality control after oxidative damage, and in subsequent cellular longevity. Plays a critical role in multiple aspects of lymphocyte development and is essential for both B and T lymphocyte survival and proliferation. Required for optimal processing and presentation of antigens for MHC II. Involved in the maintenance of axon morphology and membrane structures, as well as in normal adipocyte differentiation. Promotes primary ciliogenesis through removal of OFD1 from centriolar satellites and degradation of IFT20 via the autophagic pathway. {ECO:0000250|UniProtKB:Q99J83, ECO:0000269|PubMed:12207896, ECO:0000269|PubMed:20580051, ECO:0000269|PubMed:22170153, ECO:0000269|PubMed:26812546}.; FUNCTION: May play an important role in the apoptotic process, possibly within the modified cytoskeleton. Its expression is a relatively late event in the apoptotic process, occurring downstream of caspase activity. Plays a crucial role in IFN-gamma-induced autophagic cell death by interacting with FADD. {ECO:0000269|PubMed:15778222, ECO:0000269|PubMed:7796880}.; FUNCTION: (Microbial infection) May act as a proviral factor. In association with ATG12, negatively regulates the innate antiviral immune response by impairing the type I IFN production pathway upon vesicular stomatitis virus (VSV) infection (PubMed:17709747). Required for the translation of incoming hepatitis C virus (HCV) RNA and, thereby, for initiation of HCV replication, but not required once infection is established (PubMed:19666601). {ECO:0000269|PubMed:17709747, ECO:0000269|PubMed:19666601}. |
| Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at * Minus value of BPloci means that the break pointn is located before the CDS. |
| - In-frame and retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
| - In-frame and not-retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
| Hgene | HNRNPA2B1 | chr7:26240192 | chr6:106649964 | ENST00000354667 | - | 1 | 12 | 202_353 | 2.0 | 1115.3333333333333 | Compositional bias | Note=Gly-rich |
| Hgene | HNRNPA2B1 | chr7:26240192 | chr6:106649964 | ENST00000356674 | - | 1 | 11 | 202_353 | 2.0 | 439.3333333333333 | Compositional bias | Note=Gly-rich |
| Hgene | HNRNPA2B1 | chr7:26240192 | chr6:106649964 | ENST00000354667 | - | 1 | 12 | 112_191 | 2.0 | 1115.3333333333333 | Domain | RRM 2 |
| Hgene | HNRNPA2B1 | chr7:26240192 | chr6:106649964 | ENST00000354667 | - | 1 | 12 | 21_104 | 2.0 | 1115.3333333333333 | Domain | RRM 1 |
| Hgene | HNRNPA2B1 | chr7:26240192 | chr6:106649964 | ENST00000356674 | - | 1 | 11 | 112_191 | 2.0 | 439.3333333333333 | Domain | RRM 2 |
| Hgene | HNRNPA2B1 | chr7:26240192 | chr6:106649964 | ENST00000356674 | - | 1 | 11 | 21_104 | 2.0 | 439.3333333333333 | Domain | RRM 1 |
| Hgene | HNRNPA2B1 | chr7:26240192 | chr6:106649964 | ENST00000354667 | - | 1 | 12 | 9_15 | 2.0 | 1115.3333333333333 | Motif | Nuclear localization signal |
| Hgene | HNRNPA2B1 | chr7:26240192 | chr6:106649964 | ENST00000356674 | - | 1 | 11 | 9_15 | 2.0 | 439.3333333333333 | Motif | Nuclear localization signal |
| Hgene | HNRNPA2B1 | chr7:26240192 | chr6:106649964 | ENST00000354667 | - | 1 | 12 | 193_353 | 2.0 | 1115.3333333333333 | Region | Low complexity (LC) region |
| Hgene | HNRNPA2B1 | chr7:26240192 | chr6:106649964 | ENST00000354667 | - | 1 | 12 | 308_347 | 2.0 | 1115.3333333333333 | Region | Nuclear targeting sequence |
| Hgene | HNRNPA2B1 | chr7:26240192 | chr6:106649964 | ENST00000356674 | - | 1 | 11 | 193_353 | 2.0 | 439.3333333333333 | Region | Low complexity (LC) region |
| Hgene | HNRNPA2B1 | chr7:26240192 | chr6:106649964 | ENST00000356674 | - | 1 | 11 | 308_347 | 2.0 | 439.3333333333333 | Region | Nuclear targeting sequence |
Top |
Fusion Gene Sequence for HNRNPA2B1-ATG5 |
| For in-frame fusion transcripts, we provide the fusion transcript sequences and fusion amino acid sequences. To have fusion amino acid sequence, we ran ORFfinder and chose the longest ORF among the all predicted ones. |
| >In-frame_ENST00000354667_ENST00000343245_TCGA-CD-8525-01A_HNRNPA2B1_chr7_26240192_-_ATG5_chr6_106649964_length(transcript)=2494nt_BP=175nt AGTAGCAGCAGCGCCGGGTCCCGTGCGGAGGTGCTCCTCGCAGAGTTGTTTCTCGAGCAGCGGCAGTTCTCACTACAGCGCCAGGACGAG TCCGGTTCGTGTTCGTCCGCGGAGATCTCTCTCATCTCGCTCGGCTGCGGGAAATCGGGCTGAAGCGACTGAGTCCGCGATGGAGACAAC GACTGAAAGACCTTTCATTCAGAAGCTGTTTCGTCCTGTGGCTGCAGATGGACAGTTGCACACACTAGGAGATCTCCTCAAAGAAGTTTG TCCTTCTGCTATTGATCCTGAAGATGGGGAAAAAAAGAATCAAGTGATGATTCATGGAATTGAGCCAATGTTGGAAACACCTCTGCAGTG GCTGAGTGAACATCTGAGCTACCCGGATAATTTTCTTCATATTAGTATCATCCCACAGCCAACAGATTGAAGGATCAACTATTTGCCTGA ACAGAATCATCCTTAAATGGGATTTATCAGAGCATGTCACCCTTTTGCTTCAATCAGGTTTGGTGGAGGCAACCTGACCAGAAACACTTC GCTGCTGCAAGCCAGACAGGAAAAAGATTCCATGTCAGATAAGGCAACTGGGCTGGTCTTACTTTGCATCACCTCTGCTTTCCTCCACTG CCATCATTAAACCTCAGCTGTGACATGAAAGACTTACCGGACCACTGAAGGTCTTCTGTAAAATATAATGAAGCTGAAACCTTTGGCCTA AGAAGAAAATGGAAGTATGTGCCACTCGATTTGTATTTCTGATTAACAAATAAACAGGGGTATTTCCTAAGGTGACCATGGTTGAACTTT AGCTCATGAAAGTGGAAACATTGGTTTAATTTTCAAGAGAATTAAGAAAGTAAAAGAGAAATTCTGTTATCAATAACTTGCAAGTAATTT TTTGTAAAAGATTGAATTACAGTAAACCCATCTTTCCTTAACGAAAATTTCCTATGTTTACAGTCTGTCTATTGGTATGCAATCTTGTAA CTTTGATAATGAACAGTGAGAGATTTTTAAATAAAGCCTCTAAATATGTTTTGTCATTTAATAACATACAGTTTTGTCACTTTTCAAGTA CTTTCTGACTCACATACAGTAGATCACTTTTTACTCTGTGTTACCATTTTGACTGGTCGTCATTGGCATGGGGTGGATATAGGGCATAGG ATTACTTGTCTCAGAAGCTGTCATAGAATTTCTTGCTGCCAATTAAAAAACCTGTGTTCTTTACACACTACACGTATAAATATTGTAACT GTTCATCTTTGTTGTTTTATCACTGTAAGCCTGTCAAATCATAGTATCCTAAGCATCTGTAAATGCTAATTTTGCATTTTTGGAAAAACC CATTCCTTCCAAGCTAGTGTTTTTCATTGGCTCCAGGTCTAATTTTTCACTGTGGTCCCTGGCAGCCAGTCTTTTGAAGTTTAAAGATTA CCTGTCTCTTGACTGCAGTACCTTTTCTTTAATTTTTACCAAAAATATCCAGAGGTTACTGGAGTTCTTATTCAATATAAGGAAAGTTTG CTGCACTTTATTACCAAGCCTCTGGGATTTTACCAGTCAAACATATTTGTGCATTACATTTCATTTCTTGTGAGCTAGCTGGCTGTCCAT ATTGAATGTTGACCCATTTGAGTACGCTAAAAGGCTTACAGTATCAGACACGATCATGGTTTTAGATCCCATAATAAAAATGAATGTTTT TCTTATAAAAAATTATACAAATGCTGAAGTGAGATTCTACTATTGTTCATTGCTTCCTTTTCTTTTTCCTTTTGCGATTTTCACTGATTA ATAGCACATTTCTTCACAAAATTAGATAAAGTTGGTCAAAGACCAGATATTCTGGAATGGAAATTGTAAAGCTTAATCAAAAAGAATAGC CAGTACAGCATACAATCTCAGAAACTTAGAAGCAAGTAGAAAATAATTGGTTGATGTAAACGAAAGTGCCATTTTAGTAAAGGCAGGAAA AAAATAGCAATATTTGAGTTATGTAAGGATAAAAAATCCACTGACTTGTATTTTTGCACAAGAGGCTGGTCTGAATATGATTGTTCACAT TAAGAGTGTTTATTCGTCGGTTCATTTTGGGGATTTTCCCCCTTGATGTTTTGACAGATTGAAGTGAGCTTTAGTGAGCAAAAGGATCAG AATGCAGGGAACACTAAGCTGTGATGAAGAAAGTGTGGTAAAAAGCCAGAGTAGTTTTATACAGACAAAACCAGTGTCAGGCCTTTGCAG TAGGCTTGAGTGAACTTCTGATCTAGATTTGAAAGTAAATTTTATGAAGACATTGCCCATTTTTACTTCCTCATTCATTATTGTACCAGC ATCATAGCTTTATTACTCTAATCCCAGGTAAGTCAAGCCTACAATGCCCTAGAGGAAGAGTAAAACCAGAAATTCATGCTGGCTTAAATA >In-frame_ENST00000354667_ENST00000343245_TCGA-CD-8525-01A_HNRNPA2B1_chr7_26240192_-_ATG5_chr6_106649964_length(amino acids)=97AA_start in transcript=1035_stop in transcript=1328 MFCHLITYSFVTFQVLSDSHTVDHFLLCVTILTGRHWHGVDIGHRITCLRSCHRISCCQLKNLCSLHTTRINIVTVHLCCFITVSLSNHS -------------------------------------------------------------- >In-frame_ENST00000354667_ENST00000369070_TCGA-CD-8525-01A_HNRNPA2B1_chr7_26240192_-_ATG5_chr6_106649964_length(transcript)=2494nt_BP=175nt AGTAGCAGCAGCGCCGGGTCCCGTGCGGAGGTGCTCCTCGCAGAGTTGTTTCTCGAGCAGCGGCAGTTCTCACTACAGCGCCAGGACGAG TCCGGTTCGTGTTCGTCCGCGGAGATCTCTCTCATCTCGCTCGGCTGCGGGAAATCGGGCTGAAGCGACTGAGTCCGCGATGGAGACAAC GACTGAAAGACCTTTCATTCAGAAGCTGTTTCGTCCTGTGGCTGCAGATGGACAGTTGCACACACTAGGAGATCTCCTCAAAGAAGTTTG TCCTTCTGCTATTGATCCTGAAGATGGGGAAAAAAAGAATCAAGTGATGATTCATGGAATTGAGCCAATGTTGGAAACACCTCTGCAGTG GCTGAGTGAACATCTGAGCTACCCGGATAATTTTCTTCATATTAGTATCATCCCACAGCCAACAGATTGAAGGATCAACTATTTGCCTGA ACAGAATCATCCTTAAATGGGATTTATCAGAGCATGTCACCCTTTTGCTTCAATCAGGTTTGGTGGAGGCAACCTGACCAGAAACACTTC GCTGCTGCAAGCCAGACAGGAAAAAGATTCCATGTCAGATAAGGCAACTGGGCTGGTCTTACTTTGCATCACCTCTGCTTTCCTCCACTG CCATCATTAAACCTCAGCTGTGACATGAAAGACTTACCGGACCACTGAAGGTCTTCTGTAAAATATAATGAAGCTGAAACCTTTGGCCTA AGAAGAAAATGGAAGTATGTGCCACTCGATTTGTATTTCTGATTAACAAATAAACAGGGGTATTTCCTAAGGTGACCATGGTTGAACTTT AGCTCATGAAAGTGGAAACATTGGTTTAATTTTCAAGAGAATTAAGAAAGTAAAAGAGAAATTCTGTTATCAATAACTTGCAAGTAATTT TTTGTAAAAGATTGAATTACAGTAAACCCATCTTTCCTTAACGAAAATTTCCTATGTTTACAGTCTGTCTATTGGTATGCAATCTTGTAA CTTTGATAATGAACAGTGAGAGATTTTTAAATAAAGCCTCTAAATATGTTTTGTCATTTAATAACATACAGTTTTGTCACTTTTCAAGTA CTTTCTGACTCACATACAGTAGATCACTTTTTACTCTGTGTTACCATTTTGACTGGTCGTCATTGGCATGGGGTGGATATAGGGCATAGG ATTACTTGTCTCAGAAGCTGTCATAGAATTTCTTGCTGCCAATTAAAAAACCTGTGTTCTTTACACACTACACGTATAAATATTGTAACT GTTCATCTTTGTTGTTTTATCACTGTAAGCCTGTCAAATCATAGTATCCTAAGCATCTGTAAATGCTAATTTTGCATTTTTGGAAAAACC CATTCCTTCCAAGCTAGTGTTTTTCATTGGCTCCAGGTCTAATTTTTCACTGTGGTCCCTGGCAGCCAGTCTTTTGAAGTTTAAAGATTA CCTGTCTCTTGACTGCAGTACCTTTTCTTTAATTTTTACCAAAAATATCCAGAGGTTACTGGAGTTCTTATTCAATATAAGGAAAGTTTG CTGCACTTTATTACCAAGCCTCTGGGATTTTACCAGTCAAACATATTTGTGCATTACATTTCATTTCTTGTGAGCTAGCTGGCTGTCCAT ATTGAATGTTGACCCATTTGAGTACGCTAAAAGGCTTACAGTATCAGACACGATCATGGTTTTAGATCCCATAATAAAAATGAATGTTTT TCTTATAAAAAATTATACAAATGCTGAAGTGAGATTCTACTATTGTTCATTGCTTCCTTTTCTTTTTCCTTTTGCGATTTTCACTGATTA ATAGCACATTTCTTCACAAAATTAGATAAAGTTGGTCAAAGACCAGATATTCTGGAATGGAAATTGTAAAGCTTAATCAAAAAGAATAGC CAGTACAGCATACAATCTCAGAAACTTAGAAGCAAGTAGAAAATAATTGGTTGATGTAAACGAAAGTGCCATTTTAGTAAAGGCAGGAAA AAAATAGCAATATTTGAGTTATGTAAGGATAAAAAATCCACTGACTTGTATTTTTGCACAAGAGGCTGGTCTGAATATGATTGTTCACAT TAAGAGTGTTTATTCGTCGGTTCATTTTGGGGATTTTCCCCCTTGATGTTTTGACAGATTGAAGTGAGCTTTAGTGAGCAAAAGGATCAG AATGCAGGGAACACTAAGCTGTGATGAAGAAAGTGTGGTAAAAAGCCAGAGTAGTTTTATACAGACAAAACCAGTGTCAGGCCTTTGCAG TAGGCTTGAGTGAACTTCTGATCTAGATTTGAAAGTAAATTTTATGAAGACATTGCCCATTTTTACTTCCTCATTCATTATTGTACCAGC ATCATAGCTTTATTACTCTAATCCCAGGTAAGTCAAGCCTACAATGCCCTAGAGGAAGAGTAAAACCAGAAATTCATGCTGGCTTAAATA >In-frame_ENST00000354667_ENST00000369070_TCGA-CD-8525-01A_HNRNPA2B1_chr7_26240192_-_ATG5_chr6_106649964_length(amino acids)=97AA_start in transcript=1035_stop in transcript=1328 MFCHLITYSFVTFQVLSDSHTVDHFLLCVTILTGRHWHGVDIGHRITCLRSCHRISCCQLKNLCSLHTTRINIVTVHLCCFITVSLSNHS -------------------------------------------------------------- >In-frame_ENST00000354667_ENST00000369076_TCGA-CD-8525-01A_HNRNPA2B1_chr7_26240192_-_ATG5_chr6_106649964_length(transcript)=2494nt_BP=175nt AGTAGCAGCAGCGCCGGGTCCCGTGCGGAGGTGCTCCTCGCAGAGTTGTTTCTCGAGCAGCGGCAGTTCTCACTACAGCGCCAGGACGAG TCCGGTTCGTGTTCGTCCGCGGAGATCTCTCTCATCTCGCTCGGCTGCGGGAAATCGGGCTGAAGCGACTGAGTCCGCGATGGAGACAAC GACTGAAAGACCTTTCATTCAGAAGCTGTTTCGTCCTGTGGCTGCAGATGGACAGTTGCACACACTAGGAGATCTCCTCAAAGAAGTTTG TCCTTCTGCTATTGATCCTGAAGATGGGGAAAAAAAGAATCAAGTGATGATTCATGGAATTGAGCCAATGTTGGAAACACCTCTGCAGTG GCTGAGTGAACATCTGAGCTACCCGGATAATTTTCTTCATATTAGTATCATCCCACAGCCAACAGATTGAAGGATCAACTATTTGCCTGA ACAGAATCATCCTTAAATGGGATTTATCAGAGCATGTCACCCTTTTGCTTCAATCAGGTTTGGTGGAGGCAACCTGACCAGAAACACTTC GCTGCTGCAAGCCAGACAGGAAAAAGATTCCATGTCAGATAAGGCAACTGGGCTGGTCTTACTTTGCATCACCTCTGCTTTCCTCCACTG CCATCATTAAACCTCAGCTGTGACATGAAAGACTTACCGGACCACTGAAGGTCTTCTGTAAAATATAATGAAGCTGAAACCTTTGGCCTA AGAAGAAAATGGAAGTATGTGCCACTCGATTTGTATTTCTGATTAACAAATAAACAGGGGTATTTCCTAAGGTGACCATGGTTGAACTTT AGCTCATGAAAGTGGAAACATTGGTTTAATTTTCAAGAGAATTAAGAAAGTAAAAGAGAAATTCTGTTATCAATAACTTGCAAGTAATTT TTTGTAAAAGATTGAATTACAGTAAACCCATCTTTCCTTAACGAAAATTTCCTATGTTTACAGTCTGTCTATTGGTATGCAATCTTGTAA CTTTGATAATGAACAGTGAGAGATTTTTAAATAAAGCCTCTAAATATGTTTTGTCATTTAATAACATACAGTTTTGTCACTTTTCAAGTA CTTTCTGACTCACATACAGTAGATCACTTTTTACTCTGTGTTACCATTTTGACTGGTCGTCATTGGCATGGGGTGGATATAGGGCATAGG ATTACTTGTCTCAGAAGCTGTCATAGAATTTCTTGCTGCCAATTAAAAAACCTGTGTTCTTTACACACTACACGTATAAATATTGTAACT GTTCATCTTTGTTGTTTTATCACTGTAAGCCTGTCAAATCATAGTATCCTAAGCATCTGTAAATGCTAATTTTGCATTTTTGGAAAAACC CATTCCTTCCAAGCTAGTGTTTTTCATTGGCTCCAGGTCTAATTTTTCACTGTGGTCCCTGGCAGCCAGTCTTTTGAAGTTTAAAGATTA CCTGTCTCTTGACTGCAGTACCTTTTCTTTAATTTTTACCAAAAATATCCAGAGGTTACTGGAGTTCTTATTCAATATAAGGAAAGTTTG CTGCACTTTATTACCAAGCCTCTGGGATTTTACCAGTCAAACATATTTGTGCATTACATTTCATTTCTTGTGAGCTAGCTGGCTGTCCAT ATTGAATGTTGACCCATTTGAGTACGCTAAAAGGCTTACAGTATCAGACACGATCATGGTTTTAGATCCCATAATAAAAATGAATGTTTT TCTTATAAAAAATTATACAAATGCTGAAGTGAGATTCTACTATTGTTCATTGCTTCCTTTTCTTTTTCCTTTTGCGATTTTCACTGATTA ATAGCACATTTCTTCACAAAATTAGATAAAGTTGGTCAAAGACCAGATATTCTGGAATGGAAATTGTAAAGCTTAATCAAAAAGAATAGC CAGTACAGCATACAATCTCAGAAACTTAGAAGCAAGTAGAAAATAATTGGTTGATGTAAACGAAAGTGCCATTTTAGTAAAGGCAGGAAA AAAATAGCAATATTTGAGTTATGTAAGGATAAAAAATCCACTGACTTGTATTTTTGCACAAGAGGCTGGTCTGAATATGATTGTTCACAT TAAGAGTGTTTATTCGTCGGTTCATTTTGGGGATTTTCCCCCTTGATGTTTTGACAGATTGAAGTGAGCTTTAGTGAGCAAAAGGATCAG AATGCAGGGAACACTAAGCTGTGATGAAGAAAGTGTGGTAAAAAGCCAGAGTAGTTTTATACAGACAAAACCAGTGTCAGGCCTTTGCAG TAGGCTTGAGTGAACTTCTGATCTAGATTTGAAAGTAAATTTTATGAAGACATTGCCCATTTTTACTTCCTCATTCATTATTGTACCAGC ATCATAGCTTTATTACTCTAATCCCAGGTAAGTCAAGCCTACAATGCCCTAGAGGAAGAGTAAAACCAGAAATTCATGCTGGCTTAAATA >In-frame_ENST00000354667_ENST00000369076_TCGA-CD-8525-01A_HNRNPA2B1_chr7_26240192_-_ATG5_chr6_106649964_length(amino acids)=97AA_start in transcript=1035_stop in transcript=1328 MFCHLITYSFVTFQVLSDSHTVDHFLLCVTILTGRHWHGVDIGHRITCLRSCHRISCCQLKNLCSLHTTRINIVTVHLCCFITVSLSNHS -------------------------------------------------------------- >In-frame_ENST00000356674_ENST00000343245_TCGA-CD-8525-01A_HNRNPA2B1_chr7_26240192_-_ATG5_chr6_106649964_length(transcript)=2494nt_BP=175nt AGTAGCAGCAGCGCCGGGTCCCGTGCGGAGGTGCTCCTCGCAGAGTTGTTTCTCGAGCAGCGGCAGTTCTCACTACAGCGCCAGGACGAG TCCGGTTCGTGTTCGTCCGCGGAGATCTCTCTCATCTCGCTCGGCTGCGGGAAATCGGGCTGAAGCGACTGAGTCCGCGATGGAGACAAC GACTGAAAGACCTTTCATTCAGAAGCTGTTTCGTCCTGTGGCTGCAGATGGACAGTTGCACACACTAGGAGATCTCCTCAAAGAAGTTTG TCCTTCTGCTATTGATCCTGAAGATGGGGAAAAAAAGAATCAAGTGATGATTCATGGAATTGAGCCAATGTTGGAAACACCTCTGCAGTG GCTGAGTGAACATCTGAGCTACCCGGATAATTTTCTTCATATTAGTATCATCCCACAGCCAACAGATTGAAGGATCAACTATTTGCCTGA ACAGAATCATCCTTAAATGGGATTTATCAGAGCATGTCACCCTTTTGCTTCAATCAGGTTTGGTGGAGGCAACCTGACCAGAAACACTTC GCTGCTGCAAGCCAGACAGGAAAAAGATTCCATGTCAGATAAGGCAACTGGGCTGGTCTTACTTTGCATCACCTCTGCTTTCCTCCACTG CCATCATTAAACCTCAGCTGTGACATGAAAGACTTACCGGACCACTGAAGGTCTTCTGTAAAATATAATGAAGCTGAAACCTTTGGCCTA AGAAGAAAATGGAAGTATGTGCCACTCGATTTGTATTTCTGATTAACAAATAAACAGGGGTATTTCCTAAGGTGACCATGGTTGAACTTT AGCTCATGAAAGTGGAAACATTGGTTTAATTTTCAAGAGAATTAAGAAAGTAAAAGAGAAATTCTGTTATCAATAACTTGCAAGTAATTT TTTGTAAAAGATTGAATTACAGTAAACCCATCTTTCCTTAACGAAAATTTCCTATGTTTACAGTCTGTCTATTGGTATGCAATCTTGTAA CTTTGATAATGAACAGTGAGAGATTTTTAAATAAAGCCTCTAAATATGTTTTGTCATTTAATAACATACAGTTTTGTCACTTTTCAAGTA CTTTCTGACTCACATACAGTAGATCACTTTTTACTCTGTGTTACCATTTTGACTGGTCGTCATTGGCATGGGGTGGATATAGGGCATAGG ATTACTTGTCTCAGAAGCTGTCATAGAATTTCTTGCTGCCAATTAAAAAACCTGTGTTCTTTACACACTACACGTATAAATATTGTAACT GTTCATCTTTGTTGTTTTATCACTGTAAGCCTGTCAAATCATAGTATCCTAAGCATCTGTAAATGCTAATTTTGCATTTTTGGAAAAACC CATTCCTTCCAAGCTAGTGTTTTTCATTGGCTCCAGGTCTAATTTTTCACTGTGGTCCCTGGCAGCCAGTCTTTTGAAGTTTAAAGATTA CCTGTCTCTTGACTGCAGTACCTTTTCTTTAATTTTTACCAAAAATATCCAGAGGTTACTGGAGTTCTTATTCAATATAAGGAAAGTTTG CTGCACTTTATTACCAAGCCTCTGGGATTTTACCAGTCAAACATATTTGTGCATTACATTTCATTTCTTGTGAGCTAGCTGGCTGTCCAT ATTGAATGTTGACCCATTTGAGTACGCTAAAAGGCTTACAGTATCAGACACGATCATGGTTTTAGATCCCATAATAAAAATGAATGTTTT TCTTATAAAAAATTATACAAATGCTGAAGTGAGATTCTACTATTGTTCATTGCTTCCTTTTCTTTTTCCTTTTGCGATTTTCACTGATTA ATAGCACATTTCTTCACAAAATTAGATAAAGTTGGTCAAAGACCAGATATTCTGGAATGGAAATTGTAAAGCTTAATCAAAAAGAATAGC CAGTACAGCATACAATCTCAGAAACTTAGAAGCAAGTAGAAAATAATTGGTTGATGTAAACGAAAGTGCCATTTTAGTAAAGGCAGGAAA AAAATAGCAATATTTGAGTTATGTAAGGATAAAAAATCCACTGACTTGTATTTTTGCACAAGAGGCTGGTCTGAATATGATTGTTCACAT TAAGAGTGTTTATTCGTCGGTTCATTTTGGGGATTTTCCCCCTTGATGTTTTGACAGATTGAAGTGAGCTTTAGTGAGCAAAAGGATCAG AATGCAGGGAACACTAAGCTGTGATGAAGAAAGTGTGGTAAAAAGCCAGAGTAGTTTTATACAGACAAAACCAGTGTCAGGCCTTTGCAG TAGGCTTGAGTGAACTTCTGATCTAGATTTGAAAGTAAATTTTATGAAGACATTGCCCATTTTTACTTCCTCATTCATTATTGTACCAGC ATCATAGCTTTATTACTCTAATCCCAGGTAAGTCAAGCCTACAATGCCCTAGAGGAAGAGTAAAACCAGAAATTCATGCTGGCTTAAATA >In-frame_ENST00000356674_ENST00000343245_TCGA-CD-8525-01A_HNRNPA2B1_chr7_26240192_-_ATG5_chr6_106649964_length(amino acids)=97AA_start in transcript=1035_stop in transcript=1328 MFCHLITYSFVTFQVLSDSHTVDHFLLCVTILTGRHWHGVDIGHRITCLRSCHRISCCQLKNLCSLHTTRINIVTVHLCCFITVSLSNHS -------------------------------------------------------------- >In-frame_ENST00000356674_ENST00000369070_TCGA-CD-8525-01A_HNRNPA2B1_chr7_26240192_-_ATG5_chr6_106649964_length(transcript)=2494nt_BP=175nt AGTAGCAGCAGCGCCGGGTCCCGTGCGGAGGTGCTCCTCGCAGAGTTGTTTCTCGAGCAGCGGCAGTTCTCACTACAGCGCCAGGACGAG TCCGGTTCGTGTTCGTCCGCGGAGATCTCTCTCATCTCGCTCGGCTGCGGGAAATCGGGCTGAAGCGACTGAGTCCGCGATGGAGACAAC GACTGAAAGACCTTTCATTCAGAAGCTGTTTCGTCCTGTGGCTGCAGATGGACAGTTGCACACACTAGGAGATCTCCTCAAAGAAGTTTG TCCTTCTGCTATTGATCCTGAAGATGGGGAAAAAAAGAATCAAGTGATGATTCATGGAATTGAGCCAATGTTGGAAACACCTCTGCAGTG GCTGAGTGAACATCTGAGCTACCCGGATAATTTTCTTCATATTAGTATCATCCCACAGCCAACAGATTGAAGGATCAACTATTTGCCTGA ACAGAATCATCCTTAAATGGGATTTATCAGAGCATGTCACCCTTTTGCTTCAATCAGGTTTGGTGGAGGCAACCTGACCAGAAACACTTC GCTGCTGCAAGCCAGACAGGAAAAAGATTCCATGTCAGATAAGGCAACTGGGCTGGTCTTACTTTGCATCACCTCTGCTTTCCTCCACTG CCATCATTAAACCTCAGCTGTGACATGAAAGACTTACCGGACCACTGAAGGTCTTCTGTAAAATATAATGAAGCTGAAACCTTTGGCCTA AGAAGAAAATGGAAGTATGTGCCACTCGATTTGTATTTCTGATTAACAAATAAACAGGGGTATTTCCTAAGGTGACCATGGTTGAACTTT AGCTCATGAAAGTGGAAACATTGGTTTAATTTTCAAGAGAATTAAGAAAGTAAAAGAGAAATTCTGTTATCAATAACTTGCAAGTAATTT TTTGTAAAAGATTGAATTACAGTAAACCCATCTTTCCTTAACGAAAATTTCCTATGTTTACAGTCTGTCTATTGGTATGCAATCTTGTAA CTTTGATAATGAACAGTGAGAGATTTTTAAATAAAGCCTCTAAATATGTTTTGTCATTTAATAACATACAGTTTTGTCACTTTTCAAGTA CTTTCTGACTCACATACAGTAGATCACTTTTTACTCTGTGTTACCATTTTGACTGGTCGTCATTGGCATGGGGTGGATATAGGGCATAGG ATTACTTGTCTCAGAAGCTGTCATAGAATTTCTTGCTGCCAATTAAAAAACCTGTGTTCTTTACACACTACACGTATAAATATTGTAACT GTTCATCTTTGTTGTTTTATCACTGTAAGCCTGTCAAATCATAGTATCCTAAGCATCTGTAAATGCTAATTTTGCATTTTTGGAAAAACC CATTCCTTCCAAGCTAGTGTTTTTCATTGGCTCCAGGTCTAATTTTTCACTGTGGTCCCTGGCAGCCAGTCTTTTGAAGTTTAAAGATTA CCTGTCTCTTGACTGCAGTACCTTTTCTTTAATTTTTACCAAAAATATCCAGAGGTTACTGGAGTTCTTATTCAATATAAGGAAAGTTTG CTGCACTTTATTACCAAGCCTCTGGGATTTTACCAGTCAAACATATTTGTGCATTACATTTCATTTCTTGTGAGCTAGCTGGCTGTCCAT ATTGAATGTTGACCCATTTGAGTACGCTAAAAGGCTTACAGTATCAGACACGATCATGGTTTTAGATCCCATAATAAAAATGAATGTTTT TCTTATAAAAAATTATACAAATGCTGAAGTGAGATTCTACTATTGTTCATTGCTTCCTTTTCTTTTTCCTTTTGCGATTTTCACTGATTA ATAGCACATTTCTTCACAAAATTAGATAAAGTTGGTCAAAGACCAGATATTCTGGAATGGAAATTGTAAAGCTTAATCAAAAAGAATAGC CAGTACAGCATACAATCTCAGAAACTTAGAAGCAAGTAGAAAATAATTGGTTGATGTAAACGAAAGTGCCATTTTAGTAAAGGCAGGAAA AAAATAGCAATATTTGAGTTATGTAAGGATAAAAAATCCACTGACTTGTATTTTTGCACAAGAGGCTGGTCTGAATATGATTGTTCACAT TAAGAGTGTTTATTCGTCGGTTCATTTTGGGGATTTTCCCCCTTGATGTTTTGACAGATTGAAGTGAGCTTTAGTGAGCAAAAGGATCAG AATGCAGGGAACACTAAGCTGTGATGAAGAAAGTGTGGTAAAAAGCCAGAGTAGTTTTATACAGACAAAACCAGTGTCAGGCCTTTGCAG TAGGCTTGAGTGAACTTCTGATCTAGATTTGAAAGTAAATTTTATGAAGACATTGCCCATTTTTACTTCCTCATTCATTATTGTACCAGC ATCATAGCTTTATTACTCTAATCCCAGGTAAGTCAAGCCTACAATGCCCTAGAGGAAGAGTAAAACCAGAAATTCATGCTGGCTTAAATA >In-frame_ENST00000356674_ENST00000369070_TCGA-CD-8525-01A_HNRNPA2B1_chr7_26240192_-_ATG5_chr6_106649964_length(amino acids)=97AA_start in transcript=1035_stop in transcript=1328 MFCHLITYSFVTFQVLSDSHTVDHFLLCVTILTGRHWHGVDIGHRITCLRSCHRISCCQLKNLCSLHTTRINIVTVHLCCFITVSLSNHS -------------------------------------------------------------- >In-frame_ENST00000356674_ENST00000369076_TCGA-CD-8525-01A_HNRNPA2B1_chr7_26240192_-_ATG5_chr6_106649964_length(transcript)=2494nt_BP=175nt AGTAGCAGCAGCGCCGGGTCCCGTGCGGAGGTGCTCCTCGCAGAGTTGTTTCTCGAGCAGCGGCAGTTCTCACTACAGCGCCAGGACGAG TCCGGTTCGTGTTCGTCCGCGGAGATCTCTCTCATCTCGCTCGGCTGCGGGAAATCGGGCTGAAGCGACTGAGTCCGCGATGGAGACAAC GACTGAAAGACCTTTCATTCAGAAGCTGTTTCGTCCTGTGGCTGCAGATGGACAGTTGCACACACTAGGAGATCTCCTCAAAGAAGTTTG TCCTTCTGCTATTGATCCTGAAGATGGGGAAAAAAAGAATCAAGTGATGATTCATGGAATTGAGCCAATGTTGGAAACACCTCTGCAGTG GCTGAGTGAACATCTGAGCTACCCGGATAATTTTCTTCATATTAGTATCATCCCACAGCCAACAGATTGAAGGATCAACTATTTGCCTGA ACAGAATCATCCTTAAATGGGATTTATCAGAGCATGTCACCCTTTTGCTTCAATCAGGTTTGGTGGAGGCAACCTGACCAGAAACACTTC GCTGCTGCAAGCCAGACAGGAAAAAGATTCCATGTCAGATAAGGCAACTGGGCTGGTCTTACTTTGCATCACCTCTGCTTTCCTCCACTG CCATCATTAAACCTCAGCTGTGACATGAAAGACTTACCGGACCACTGAAGGTCTTCTGTAAAATATAATGAAGCTGAAACCTTTGGCCTA AGAAGAAAATGGAAGTATGTGCCACTCGATTTGTATTTCTGATTAACAAATAAACAGGGGTATTTCCTAAGGTGACCATGGTTGAACTTT AGCTCATGAAAGTGGAAACATTGGTTTAATTTTCAAGAGAATTAAGAAAGTAAAAGAGAAATTCTGTTATCAATAACTTGCAAGTAATTT TTTGTAAAAGATTGAATTACAGTAAACCCATCTTTCCTTAACGAAAATTTCCTATGTTTACAGTCTGTCTATTGGTATGCAATCTTGTAA CTTTGATAATGAACAGTGAGAGATTTTTAAATAAAGCCTCTAAATATGTTTTGTCATTTAATAACATACAGTTTTGTCACTTTTCAAGTA CTTTCTGACTCACATACAGTAGATCACTTTTTACTCTGTGTTACCATTTTGACTGGTCGTCATTGGCATGGGGTGGATATAGGGCATAGG ATTACTTGTCTCAGAAGCTGTCATAGAATTTCTTGCTGCCAATTAAAAAACCTGTGTTCTTTACACACTACACGTATAAATATTGTAACT GTTCATCTTTGTTGTTTTATCACTGTAAGCCTGTCAAATCATAGTATCCTAAGCATCTGTAAATGCTAATTTTGCATTTTTGGAAAAACC CATTCCTTCCAAGCTAGTGTTTTTCATTGGCTCCAGGTCTAATTTTTCACTGTGGTCCCTGGCAGCCAGTCTTTTGAAGTTTAAAGATTA CCTGTCTCTTGACTGCAGTACCTTTTCTTTAATTTTTACCAAAAATATCCAGAGGTTACTGGAGTTCTTATTCAATATAAGGAAAGTTTG CTGCACTTTATTACCAAGCCTCTGGGATTTTACCAGTCAAACATATTTGTGCATTACATTTCATTTCTTGTGAGCTAGCTGGCTGTCCAT ATTGAATGTTGACCCATTTGAGTACGCTAAAAGGCTTACAGTATCAGACACGATCATGGTTTTAGATCCCATAATAAAAATGAATGTTTT TCTTATAAAAAATTATACAAATGCTGAAGTGAGATTCTACTATTGTTCATTGCTTCCTTTTCTTTTTCCTTTTGCGATTTTCACTGATTA ATAGCACATTTCTTCACAAAATTAGATAAAGTTGGTCAAAGACCAGATATTCTGGAATGGAAATTGTAAAGCTTAATCAAAAAGAATAGC CAGTACAGCATACAATCTCAGAAACTTAGAAGCAAGTAGAAAATAATTGGTTGATGTAAACGAAAGTGCCATTTTAGTAAAGGCAGGAAA AAAATAGCAATATTTGAGTTATGTAAGGATAAAAAATCCACTGACTTGTATTTTTGCACAAGAGGCTGGTCTGAATATGATTGTTCACAT TAAGAGTGTTTATTCGTCGGTTCATTTTGGGGATTTTCCCCCTTGATGTTTTGACAGATTGAAGTGAGCTTTAGTGAGCAAAAGGATCAG AATGCAGGGAACACTAAGCTGTGATGAAGAAAGTGTGGTAAAAAGCCAGAGTAGTTTTATACAGACAAAACCAGTGTCAGGCCTTTGCAG TAGGCTTGAGTGAACTTCTGATCTAGATTTGAAAGTAAATTTTATGAAGACATTGCCCATTTTTACTTCCTCATTCATTATTGTACCAGC ATCATAGCTTTATTACTCTAATCCCAGGTAAGTCAAGCCTACAATGCCCTAGAGGAAGAGTAAAACCAGAAATTCATGCTGGCTTAAATA >In-frame_ENST00000356674_ENST00000369076_TCGA-CD-8525-01A_HNRNPA2B1_chr7_26240192_-_ATG5_chr6_106649964_length(amino acids)=97AA_start in transcript=1035_stop in transcript=1328 MFCHLITYSFVTFQVLSDSHTVDHFLLCVTILTGRHWHGVDIGHRITCLRSCHRISCCQLKNLCSLHTTRINIVTVHLCCFITVSLSNHS -------------------------------------------------------------- |
Top |
Fusion Gene PPI Analysis for HNRNPA2B1-ATG5 |
| Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in |
| Protein-protein interactors with each fusion partner protein in wild-type (BIOGRID-3.4.160) |
| Hgene | Hgene's interactors | Tgene | Tgene's interactors |
| - Retained PPIs in in-frame fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
| - Lost PPIs in in-frame fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
| - Retained PPIs, but lost function due to frame-shift fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
Related Drugs for HNRNPA2B1-ATG5 |
| Drugs targeting genes involved in this fusion gene. (DrugBank Version 5.1.8 2021-05-08) |
| Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
| Hgene | HNRNPA2B1 | P22626 | DB09130 | Copper | Small molecule | Approved|Investigational | |
| Hgene | HNRNPA2B1 | P22626 | DB09130 | Copper | Small molecule | Approved|Investigational |
Top |
Related Diseases for HNRNPA2B1-ATG5 |
| Diseases associated with fusion partners. (DisGeNet 4.0) |
| Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
| Hgene | HNRNPA2B1 | C0002736 | Amyotrophic Lateral Sclerosis | 1 | GENOMICS_ENGLAND |
| Hgene | HNRNPA2B1 | C0023493 | Adult T-Cell Lymphoma/Leukemia | 1 | CTD_human |
| Hgene | HNRNPA2B1 | C1833662 | INCLUSION BODY MYOPATHY WITH EARLY-ONSET PAGET DISEASE AND FRONTOTEMPORAL DEMENTIA | 1 | CTD_human;ORPHANET |
| Hgene | HNRNPA2B1 | C3809468 | INCLUSION BODY MYOPATHY WITH EARLY-ONSET PAGET DISEASE WITH OR WITHOUT FRONTOTEMPORAL DEMENTIA 2 | 1 | UNIPROT |
| Tgene | ATG5 | C0002871 | Anemia | 1 | CTD_human |
| Tgene | ATG5 | C0019193 | Hepatitis, Toxic | 1 | CTD_human |
| Tgene | ATG5 | C0019209 | Hepatomegaly | 1 | CTD_human |
| Tgene | ATG5 | C0023380 | Lethargy | 1 | CTD_human |
| Tgene | ATG5 | C0024312 | Lymphopenia | 1 | CTD_human |
| Tgene | ATG5 | C0027540 | Necrosis | 1 | CTD_human |
| Tgene | ATG5 | C0860207 | Drug-Induced Liver Disease | 1 | CTD_human |
| Tgene | ATG5 | C0919267 | ovarian neoplasm | 1 | CTD_human |
| Tgene | ATG5 | C1140680 | Malignant neoplasm of ovary | 1 | CTD_human |
| Tgene | ATG5 | C1262477 | Weight decreased | 1 | CTD_human |
| Tgene | ATG5 | C1262760 | Hepatitis, Drug-Induced | 1 | CTD_human |
| Tgene | ATG5 | C3658290 | Drug-Induced Acute Liver Injury | 1 | CTD_human |
| Tgene | ATG5 | C4277682 | Chemical and Drug Induced Liver Injury | 1 | CTD_human |
| Tgene | ATG5 | C4279912 | Chemically-Induced Liver Toxicity | 1 | CTD_human |
| Tgene | ATG5 | C4539808 | SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 25 | 1 | UNIPROT |
Copyright 2021-Present -The University of Texas Health Science Center at Houston (UTHealth)
Web File Viewing | Emergency Information |Campus Carry|Site Policies